Viewing Study NCT01958866


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-02-20 @ 1:31 PM
Study NCT ID: NCT01958866
Status: COMPLETED
Last Update Posted: 2015-03-11
First Post: 2013-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen
Sponsor: Chulalongkorn University
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2015-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hypothesis: Tinospora Crispa-extract Product can reduce pyretic similar to acetaminophen.

This study aims to investigate the efficacy and safety of Tinospora Crispa-extract product compared with the acetaminophen. Total of 96 patients with body temperature between 37.8-38.5 without any signs of infections will be enrolled in this study. Patients will be randomly divided into 3 groups: First group will receive acetaminophen 1000 mg every 6 hr, Second group will receive Tinospora Crispa-extract Product 2000 mg twice daily and the third group will receive placebo twice daily.
Detailed Description: Patients in each group will be monitored for body temperature at baseline (at the time of enrollment) and at 1, 2, 4, 6, 8, 24 h after receiving the tested material.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: